Wanchana Singhan, U. Permsuwan, S. Vongsanim, Yuttitham Suteeka, S. Deeprom
{"title":"泰国接受腹膜透析患者的生活质量和接受血液透析的支付意愿","authors":"Wanchana Singhan, U. Permsuwan, S. Vongsanim, Yuttitham Suteeka, S. Deeprom","doi":"10.29090/psa.2022.04.22.054","DOIUrl":null,"url":null,"abstract":"This cross-sectional study was conducted to evaluate quality of life (QoL), willingness to pay (WTP) for receiving hemodialysis (HD), and factors influencing QoL in patients who received peritoneal dialysis (PD) in Thailand. Data of PD patients visiting secondary or tertiary hospitals from December 2020 through June 2021 were collected. EuroQoL EQ-5D-5L questionnaire was used to evaluate QoL. After the patients completed the questionnaire, they were interviewed using the contingent valuation method to derive their WTP for switching to HD. Patients randomly picked up one payment card as an initial price for receiving HD, then bidding by 100 Thai Baht (THB) up and down to reach the maximum affordable WTP amount. Multiple linear regression was used to identify factors affecting QoL. A total of 102 patients were included in this study. The mean age was 58 years. EQ-5D utility score was 0.71±0.32. Five variables were the factors that affect QoL included serum albumin, hospitalization, age, urine output, and hemoglobin level. Average WTP was 233±293 THB (7.2±9.0 USD) per HD session. Quality of life among these study patients was slightly higher than reported in Thai patients with low hemoglobin level. Treatment anemia to reach hemoglobin target and preservation of residual urine output might improve QoL. The average WTP for switching to HD among PD patients was only one-sixth of general billing price for HD.","PeriodicalId":19761,"journal":{"name":"Pharmaceutical Sciences Asia","volume":"15 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Quality of life and willingness to pay for receiving hemodialysis in patients who received peritoneal dialysis in Thailand\",\"authors\":\"Wanchana Singhan, U. Permsuwan, S. Vongsanim, Yuttitham Suteeka, S. Deeprom\",\"doi\":\"10.29090/psa.2022.04.22.054\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"This cross-sectional study was conducted to evaluate quality of life (QoL), willingness to pay (WTP) for receiving hemodialysis (HD), and factors influencing QoL in patients who received peritoneal dialysis (PD) in Thailand. Data of PD patients visiting secondary or tertiary hospitals from December 2020 through June 2021 were collected. EuroQoL EQ-5D-5L questionnaire was used to evaluate QoL. After the patients completed the questionnaire, they were interviewed using the contingent valuation method to derive their WTP for switching to HD. Patients randomly picked up one payment card as an initial price for receiving HD, then bidding by 100 Thai Baht (THB) up and down to reach the maximum affordable WTP amount. Multiple linear regression was used to identify factors affecting QoL. A total of 102 patients were included in this study. The mean age was 58 years. EQ-5D utility score was 0.71±0.32. Five variables were the factors that affect QoL included serum albumin, hospitalization, age, urine output, and hemoglobin level. Average WTP was 233±293 THB (7.2±9.0 USD) per HD session. Quality of life among these study patients was slightly higher than reported in Thai patients with low hemoglobin level. Treatment anemia to reach hemoglobin target and preservation of residual urine output might improve QoL. The average WTP for switching to HD among PD patients was only one-sixth of general billing price for HD.\",\"PeriodicalId\":19761,\"journal\":{\"name\":\"Pharmaceutical Sciences Asia\",\"volume\":\"15 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pharmaceutical Sciences Asia\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.29090/psa.2022.04.22.054\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Pharmacology, Toxicology and Pharmaceutics\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmaceutical Sciences Asia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.29090/psa.2022.04.22.054","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
Quality of life and willingness to pay for receiving hemodialysis in patients who received peritoneal dialysis in Thailand
This cross-sectional study was conducted to evaluate quality of life (QoL), willingness to pay (WTP) for receiving hemodialysis (HD), and factors influencing QoL in patients who received peritoneal dialysis (PD) in Thailand. Data of PD patients visiting secondary or tertiary hospitals from December 2020 through June 2021 were collected. EuroQoL EQ-5D-5L questionnaire was used to evaluate QoL. After the patients completed the questionnaire, they were interviewed using the contingent valuation method to derive their WTP for switching to HD. Patients randomly picked up one payment card as an initial price for receiving HD, then bidding by 100 Thai Baht (THB) up and down to reach the maximum affordable WTP amount. Multiple linear regression was used to identify factors affecting QoL. A total of 102 patients were included in this study. The mean age was 58 years. EQ-5D utility score was 0.71±0.32. Five variables were the factors that affect QoL included serum albumin, hospitalization, age, urine output, and hemoglobin level. Average WTP was 233±293 THB (7.2±9.0 USD) per HD session. Quality of life among these study patients was slightly higher than reported in Thai patients with low hemoglobin level. Treatment anemia to reach hemoglobin target and preservation of residual urine output might improve QoL. The average WTP for switching to HD among PD patients was only one-sixth of general billing price for HD.
Pharmaceutical Sciences AsiaPharmacology, Toxicology and Pharmaceutics-Pharmacology, Toxicology and Pharmaceutics (all)
CiteScore
0.90
自引率
0.00%
发文量
59
期刊介绍：
The Pharmaceutical Sciences Asia (PSA) journal is a double-blinded peer-reviewed journal in English published quarterly, by the Faculty of Pharmacy, Mahidol University, Thailand. The PSA journal is formerly known as Mahidol University Journal of Pharmaceutical Sciences and committed to the timely publication of innovative articles and reviews. This journal is available in both printed and electronic formats. The PSA journal aims at establishing a publishing house that is open to all. It aims to disseminate knowledge; provide a learned reference in the field; and establish channels of communication between academic and research expert, policy makers and executives in industry and investment institutions. The journal publishes research articles, review articles, and scientific commentaries on all aspects of the pharmaceutical sciences and multidisciplinary field in health professions and medicine. More specifically, the journal publishes research on all areas of pharmaceutical sciences and related disciplines: Clinical Pharmacy Drug Synthesis and Discovery Targeted-Drug Delivery Pharmaceutics Biopharmaceutical Sciences Phytopharmaceutical Sciences Pharmacology and Toxicology Pharmaceutical Chemistry Nutraceuticals and Functional Foods Natural Products Social, Economic, and Administrative Pharmacy Clinical Drug Evaluation and Drug Policy Making Antimicrobials, Resistance and Infection Control Pharmacokinetics and Pharmacodynamics.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
